Universal Health Services Inc

Universal Health Services Inc(UHS)股票分析

$186.890

-1.233 (-0.66%)收盘时

Loading chart…
最高
188.980
开盘
187.270
成交量加权均价
187.48
成交量
450.80K
市值
12.82B
最低
186.565
成交额
84.52M
企业价值/息税折旧摊销前利润(TTM)
5.76

Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company, UHS of Delaware, Inc. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include Acute Care Hospital Services and Behavioral Health Care Services. It owns and operates approximately 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, among others.

uhs.com

AI 分析 of Universal Health Services Inc (UHS)

持有

Universal Health Services Inc is currently priced at $186.89, which is below several analyst price targets, including $183 from RBC Capital and $170 from BofA. However, the stock has a low forward P/E of 7.26 and a strong gross margin of 100%, indicating potential value. The main risk is the company's recent performance, with a year-to-date change of -15% and a decline of -12.68% over the past year, suggesting ongoing challenges.

分析师评级(16)

上行空间 +32.70%
买入
11 买入
5 持有
0 卖出
当前: 186.89
最低
190.00
平均
248.00
最高
302.00

BofA

2026-08-10

目标价

$170

跑输大盘

RBC Capital

2026-08-03

目标价

$183

Sector Perform

Goldman Sachs

2026-07-30

目标价

$190

中性

Guggenheim

2026-07-29

目标价

$189

买入

UBS

2026-07-29

目标价

$290

买入

估值指标

Universal Health Services Inc(UHS)当前预期市盈率为 7.26,5 年平均预期市盈率为 10.75。

预期市盈率

低估
5 年均值 P/E
10.75
当前P/E
7.26
高估
12.97
低估
8.52

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
7.49
当前EV/EBITDA
5.76
高估
8.64
低估
6.34

预期市销率

低估
5 年均值 P/S
0.69
当前P/S
0.57
高估
0.80
低估
0.57

Alphio AI 对 UHS 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%UHS

$244.27

情景价格

基

基准

基准 · 50%UHS

$214.65

情景价格

悲

悲观

悲观 · 25%UHS

$205.18

情景价格

持有 UHS 的大户

M

Moore Capital Management, LP

+ 持有UHS

-6.01%

3个月收益率

事件时间线

2026-10-06 (ET)

10:30:00

CFTC Proposes Comprehensive Regulatory Framework for Crypto Assets

2026-09-28 (ET)

10:00:00

NVIDIA Stock Rises $6.95 to $232.02

2026-09-23 (ET)

10:00:00

Moderna Stock Rises $8.69 to $191.25

2026-07-27 (ET)

20:00:00

Energy Stocks Drop, Nvidia Falls 5% on AI Investment

资讯

UHS 常见问题 —— 由 Alphio AI 解答

Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company, UHS of Delaware, Inc. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include Acute Care Hospital Services and Behavioral Health Care Services. It owns and operates approximately 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, among others. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Universal Health Services Inc is currently priced at $186.89, which is below several analyst price targets, including $183 from RBC Capital and $170 from BofA. However, the stock has a low forward P/E of 7.26 and a strong gross margin of 100%, indicating potential value. The main risk is the company's recent performance, with a year-to-date change of -15% and a decline of -12.68% over the past year, suggesting ongoing challenges.

16 analysts cover UHS: 11 rate it Buy, 5 Hold and 0 Sell. The average price target is 248.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易